Mark Ingram
Impact in
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research
- Immunology top 10%
- Immune Response and Inflammation
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Micro and Nano Robotics 3
-
- Advanced Glycation End Products research 1
Mark Ingram
7 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Clinical Biochemistry 839
- Immunology 302
- Endocrinology, Diabetes and Metabolism 176
- Neurology 70
- Molecular Biology 450
Countries citing papers authored by Mark Ingram
This map shows the geographic impact of Mark Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ingram more than expected).
Fields of papers citing papers by Mark Ingram
This network shows the impact of papers produced by Mark Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ingram. The network helps show where Mark Ingram may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Ingram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 21 | |
| 2 | 2006 | 9 | |
| 3 | 2005 | 8 | |
| 4 | 2005 | 25 | |
| 5 | Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases Hit paper breakdown → | 2000 | 1058 |
| 6 | 1999 | 14 | |
| 7 | 1999 | 22 |
About Mark Ingram
Mark Ingram is a scholar working on Condensed Matter Physics, Clinical Biochemistry, Biotechnology, Immunology and Biomedical Engineering, having authored 7 papers that have together received 1.2k indexed citations. Recurring topics across this work include Micro and Nano Robotics (3 papers), Soft Robotics and Applications (3 papers), Modular Robots and Swarm Intelligence (2 papers), Muscle activation and electromyography studies (1 paper), Neural dynamics and brain function (1 paper), Advanced Glycation End Products research (1 paper), Transgenic Plants and Applications (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Clinical Biochemistry (839 citations), Immunology (302 citations), Endocrinology, Diabetes and Metabolism (176 citations), Neurology (70 citations) and Molecular Biology (450 citations). Mark Ingram has collaborated with scholars based in United States and Japan. Frequent co-authors include Evanthia Lalla, Akihiko Taguchi, Nozomu Tanji, Caifeng Fu, Osamu Hori, Yan Lu, Wu Qu, David M. Stern, Thomas Kislinger and G. Del Toro. Their work appears in journals such as Journal of Mechanisms and Robotics, Nature, Transplantation, BioMedical Engineering OnLine and Journal of Pediatric Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.